---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-211811"
form_type: "8-K"
ticker: "KOD"
cik: "0001468748"
company_name: "Kodiak Sciences Inc."
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T21:35:19.427660+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Kodiak Sciences reports Q1 net loss $0.94/sh; Zenkuda GLOW2 positive, BLA planned

## Summary
- Cash $169.5M as of March 31, 2026, expected to fund operations into 2027.
- Net loss $58.2M ($0.94/sh) vs. $57.5M ($1.09/sh) in Q1 2025.
- Zenkuda GLOW2: 62.5% ≥2-step DRSS improvement vs. 3.3% sham (p<0.0001); no vasculitis.
- DAYBREAK Phase 3 topline in wet AMD September 2026; PEAK topline in MESI 4Q 2026.
- R&D expenses rose to $48.5M from $43.6M driven by PEAK/PINNACLE and DAYBREAK studies.

## SEC filing metadata
- accession: 0001193125-26-211811
- form_type: 8-K
- ticker: KOD
- cik: 0001468748
- company_name: Kodiak Sciences Inc.
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468748/000119312526211811/0001193125-26-211811-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468748/000119312526211811/kod-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-211811
- JSON: https://secwatch.observer/filing/0001193125-26-211811.json
- Plain text: https://secwatch.observer/filing/0001193125-26-211811.txt

## Source-grounded claims
- claim_id: f9a774ed701bd6aeb8f5a9012894bb5e0a3788f3
  claim: Kodiak Sciences Inc. reported first quarter ended March 31, 2026 results: net income Net loss for the first quarter of 2026 was $58.2 million, EPS $0.94 per share on a basic and diluted basis.
  evidence_excerpt: Net loss for the first quarter of 2026 was $58.2 million, or $0.94 per share on a basic and diluted basis, as compared to a net loss of $57.5 million, or $1.09 per share on a basic and diluted basis, for the first quarter of 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468748/000119312526211811/0001193125-26-211811-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.